BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
A Primer on Lung Cancer November is the Lung Cancer Awareness Month. Lung cancer affects
FORM 7 MONTHLY PROGRESS REPORT Name of listed Issuer: BioMark Diagnostics Inc. (the “issuer”). Trading
FORM 7 MONTHLY PROGRESS REPORT Name of listed Issuer: BioMark Diagnostics Inc. (the “issuer”). Trading
BioMark Diagnostics is pleased to announce that the installation of its Quebec laboratory is now
A liquid biopsy is a test that is performed on a sample of blood taken
The article presented on this page may contain forward-looking statements. These statements relate to future
The Right Leadership and Technology Partnerships designed to deliver clinical solutions to cancer care management.
Earlier and faster cancer detection is underway in Alberta Mikenomics | April 6, 2021 Earlier
A new project funded by the Canadian Cancer Society (CCS) could transform how lung cancer
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]